GENE POLYMORPHISM OF AROMATASE IN PATIENTS WITH SEROUS OVARIAN CANCER IN THE REPUBLIC OF BELARUS
Abstract
About the Authors
А. P. MIKHALENKABelarus
S. E. SHELKOVICH
Belarus
N. V. CHEBOTAREVA
Belarus
A. N. SCHAYUK
Belarus
E. N. MAISENIA
Belarus
Yu. E. DEMIDCHIK
Belarus
E. V. KRUPNOVA
Belarus
References
1. Берштейн, Л. М. Гормональный канцерогенез / Л. М. Бернштейн. – Санкт-Петербург, 2000. – 199 с.
2. History of aromatase: saga of an important biological mediator and therapeutic target / R. J. Santen [et al.] // Endocr. Rev. – 2009. – Vol. 30, N 4. – Р. 343–375.
3. Sebastian, S. A highly complex organization of the regulatory region of the human CYP19 (aromatase) gene revealed by the Human Genome Project / S. Sebastian, S. E. Bulun // J. Clin. Endocrinol. Metab. – 2001. – Vol. 86, N 10. – P. 4600–4602.
4. Polymorphisms associated with circulating sex hormone levels in postmenopausal women / A. M. Dunning [et al.] // J. Natl. Cancer Inst. – 2004. – Vol. 96. – P. 936–945.
5. Aromatase gene and osteoporosis: relationship of ten polymorphic loci with bone mineral density / J. A. Riancho [et al.] // Bone. – 2005. – Vol. 36. – P. 917–925.
6. Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women / C. A. Haiman [et al.] // Cancer Res. – 2007. – Vol. 67. – P. 1893–1897.
7. CYP19 gene: a genetic modifier of polycystic ovary syndrome phenotype / N. Xita [et al.] // Fertil. Steril. – 2010. – Vol. 94, N 1. – P. 250–254.
8. Aromatase expression in women’s cancers. Review / S. E. Bulun [et al.] // J. Steroid Biochem. Mol. Biol. – 2007. – Vol. 106. – Р. 81–96.